Kristin Wall provides strategic legal counsel to the innovative pharmaceutical and medical device industries across a breadth of complex litigation and regulatory matters. She has extensive litigation experience under the Patented Medicines (Notice of Compliance) (PMNOC) Regulations, regulations governing the Patented Medicine Prices Review Board (PMPRB), Certificate of Supplementary Protection (CSP) Regulations and Food and Drug Regulations. Ms. Wall has acted in many of the first litigation proceedings under Canada's 2017-amended patent legislation, including as counsel in the first PMNOC and CSP court challenges. She represents pharmaceutical patentees in an industry-wide challenge of Canada’s newly amended PMPRB drug pricing regulations and guidelines. Ms. Wall's advisory work focusses on regulation that is most susceptible to litigation, including issues involving drug pricing and reimbursement, patents and data protection. Her in-depth understanding of how her clients are regulated enables Ms. Wall to develop early litigation and market exclusivity strategies. In our current challenging climate, she supports clients using Health Canada's COVID-19 approval pathways, including the Interim Order on drugs. She is editor of the firm's Pharma in Brief bulletin.